74 related articles for article (PubMed ID: 912131)
1. Evaluation and staging in the Scottish Dermatological Society mycosis fungoides register.
Mackie RM
Bull Cancer; 1977; 64(2):279-86. PubMed ID: 912131
[TBL] [Abstract][Full Text] [Related]
2. [High-grade malignant mycosis fungoides with cytological transformation (author's transl)].
Schmoeckel C; Burg G; Braun-Falco O; Klingmuller G
Ann Dermatol Venereol; 1981; 108(3):231-6, 239-41. PubMed ID: 7258982
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
4. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
[TBL] [Abstract][Full Text] [Related]
6. [Mycosis fungoides. Results of helioclimate therapy in high mountains (Davos, 1,560)].
Tippel H; Engst R
Hautarzt; 1986 Aug; 37(8):450-3. PubMed ID: 3759452
[TBL] [Abstract][Full Text] [Related]
7. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
8. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
Tourbier H; Schultz-Ehrenburg U
Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717
[TBL] [Abstract][Full Text] [Related]
9. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience.
Parida DK; Verma KK; Chander S; Joshi RC; Rath GK
Int J Dermatol; 2005 Oct; 44(10):828-30. PubMed ID: 16207183
[TBL] [Abstract][Full Text] [Related]
10. Management of mycosis fungoides. Part 1. Diagnosis, staging, and prognosis.
Smith BD; Wilson LD
Oncology (Williston Park); 2003 Sep; 17(9):1281-8. PubMed ID: 14569854
[TBL] [Abstract][Full Text] [Related]
11. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
12. Preliminary observations on the phenotypes of lymphoid cells in mycosis fungoides using anti-human-thymocyte monoclonal antibodies.
Liu J; Shi Y; Kong Q; Zhang Q; Huang J; Zeng X; Wang X; Li J; Sang H; Li A
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(4):186-7. PubMed ID: 2293225
[TBL] [Abstract][Full Text] [Related]
13. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of cutaneous T-cell lymphoma.
Abel EA
Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
[TBL] [Abstract][Full Text] [Related]
15. [The significance of epidermal changes in the early diagnosis and development of mycosis fungoides].
Persina IS; Zabanova EV; Vavilov AM; Avervakh EV
Arkh Patol; 1989; 51(2):40-6. PubMed ID: 2653281
[TBL] [Abstract][Full Text] [Related]
16. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
Kamarashev J; Theler B; Dummer R; Burg G
Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
[TBL] [Abstract][Full Text] [Related]
17. Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides.
Cen P; Duvic M; Cohen PR; Kurzrock R
J Am Acad Dermatol; 2008 Mar; 58(3):382-6. PubMed ID: 18280334
[TBL] [Abstract][Full Text] [Related]
18. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
19. [Mycosis fungoides. Clinical characteristics and treatment of 6 patients].
Dotterud LK; Aarstein K; Falk ES
Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1850-2. PubMed ID: 1853318
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]